Literature DB >> 9155666

Cerebrospinal fluid analysis in clinical diagnosis.

A O Olukoga1, J Bolodeoku, D Donaldson.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9155666      PMCID: PMC499810          DOI: 10.1136/jcp.50.3.187

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  39 in total

1.  Activity of lactic dehydrogenase in spinal fluid.

Authors:  F WROBLEWSKI; B DECKER; R WROBLEWSKI
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

2.  Proteins as parameters in the discrimination between different blood-CSF barriers.

Authors:  G Keir; E J Thompson
Journal:  J Neurol Sci       Date:  1986-10       Impact factor: 3.181

3.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

4.  Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal-fluid cells.

Authors:  A D Dayan; M I Stokes
Journal:  Lancet       Date:  1973-01-27       Impact factor: 79.321

5.  Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.

Authors:  K G Porter; D G Sinnamon; R R Gillies
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

6.  Cerebrospinal fluid C-reactive protein in meningitis: diagnostic value and pathophysiology.

Authors:  E BenGershôm; G J Briggeman-Mol; F de Zegher
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

7.  The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; T E Nance-Sproson; D E Griffin; D Hoover; O A Selnes; E N Miller; J B Margolick; B A Cohen; H Farzadegan; A Saah
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

8.  Glucose ontent in cerebrospinal fluid: a comparison with glucose levels in serum as determined by copper reduction and hexokinase methods.

Authors:  K A Greenawald; C E Speicher; W Evers; J B Henry
Journal:  Am J Clin Pathol       Date:  1973-04       Impact factor: 2.493

9.  Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.

Authors:  D E Griffin; J C McArthur; D R Cornblath
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

10.  Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.

Authors:  J N Whitaker; R P Lisak; R M Bashir; O H Fitch; J M Seyer; R Krance; J A Lawrence; L T Ch'ien; P O'Sullivan
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

View more
  2 in total

Review 1.  Clinical metabolomics: the next stage of clinical biochemistry.

Authors:  Angelo D'Alessandro; Bruno Giardina; Federica Gevi; Anna Maria Timperio; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 2.  Laboratory instrumentation in clinical biochemistry: an historical perspective.

Authors:  A O Olukoga; J Bolodeoku; D Donaldson
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.